Related Experiment Videos
Sex of first child as a prognostic factor in breast cancer
Insights
The sex of a patient's first child may impact breast cancer prognosis. Having a firstborn son correlated with a better outcome after mastectomy for potentially curable breast cancer.
Area of Science:
- Oncology
- Reproductive Endocrinology
- Cancer Prognostics
Background:
- Breast cancer prognosis is influenced by various factors.
- The role of early life exposures and hormonal influences in cancer outcomes is an area of ongoing research.
- Previous studies have explored potential links between reproductive history and breast cancer risk and outcome.
Purpose of the Study:
- To investigate whether the sex of the first child is a prognostic factor for patients undergoing mastectomy for potentially curable breast cancer.
- To explore potential biological mechanisms, such as fetal testicular secretions, that might explain any observed associations.
- To determine if the observed effect, if any, is specific to breast cancer outcome or also influences breast cancer risk.
Main Methods:
- Retrospective analysis of patients who underwent mastectomy for potentially curable breast cancer.
- Comparison of patient outcomes based on the sex of their firstborn child.
- Statistical analysis to determine the significance of observed differences.
- Subgroup analysis based on lymph node involvement.
Main Results:
- Patients whose first child was a boy demonstrated a statistically significant better outcome compared to those whose first child was a girl.
- The male/female sex ratio of firstborns was higher in patients without node involvement than in those with node involvement.
- The protective effect of a male firstborn was observed even in patients with significant lymph node involvement (≥4 nodes).
- The sex ratio of firstborns in the study was not significantly different from the general population, suggesting no increased risk of breast cancer.
Conclusions:
- The sex of the first child appears to be a significant prognostic factor in breast cancer survival post-mastectomy.
- Fetal testicular secretions from a male firstborn may offer a protective effect against breast cancer progression.
- This protective effect seems specific to outcome and does not appear to influence the overall risk of developing breast cancer.
Abstract:
The sex of the first child of patients who underwent mastectomy for potentially curable breast cancer appeared to be a valuable prognostic factor: patients whose first child was a boy had a better outcome than those whose first child was a girl. The difference was statistically significant. This may have been because the male/female sex ratio among first children was significantly higher in those patients without node involvement than in those with node involvement. But the favourable effect of a male first birth was still seen when only patients with an equal degree of node involvement (greater than or equal to 4 nodes) were studied. The "protection" resulting from a male first-born could be the result of fetal testicular secretions. This protection did not apply to the risk of breast cancer--the male/female sex ratio of first children in our series was 1.08, a figure not statistically different from that of the overall French population (1.05).